Joseph Allen, OD, FAAO, Dipl ABO
Show Description +
The first drug to treat geographic atrophy (GA) has been approved by the FDA. Joseph Allen, OD, FAAO, Dipl ABO, breaks down how pegcetacoplan injection (Syfovre, Apellis Pharmaceuticals) targets the complement pathway to slow the progression of GA, points out its safety profile, and ocular side effects.
Posted: 3/08/2023
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Justin Manning, OD, MPH, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Harbir Sian, OD
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO; and Jessilin Quint, OD, MS, MBA, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Rachael Wruble, OD, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Will To, OD, ABOC
Joseph J. Allen, OD, FAAO, Dipl ABO; and Trevor Fosso, OD, FAAO, FSCS
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Laura M. Periman, MD; and Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Jaclyn Garlich, OD, FAAO; and Joseph J. Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Saleel Jivraj, OD, MBA, FAAO, FCOptom, FBCLA
Darryl Glover, OD, Joseph Allen, OD, FAAO
Jennifer Lyerly, OD, Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Solomon Gould, OD, MBA
Joseph Allen, OD, FAAO, Solomon Gould, OD, MBA
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO; Cecelia Koetting, OD, FAAO, Dipl ABO; Jacqueline Theis, OD, FAAO, FNAP; and Jade Coats, OD
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
The first drug to treat geographic atrophy (GA) has been approved by the FDA. Joseph Allen, OD, FAAO, Dipl ABO, breaks down how pegcetacoplan injection (Syfovre, Apellis Pharmaceuticals) targets the complement pathway to slow the progression of GA, points out its safety profile, and ocular side effects.
Posted: 3/08/2023
Stanislao Rizzo, MD
Hudson de Carvalho Nakamura, MD
Frederic Aissani, MD
Manish Nagpal, MS, DO, FRCS(UK)
Please log in to leave a comment.